TRPA1 and lung cancer: The distinct outcome of ROS-dependent TRPA1 activation in different cancer types, e.g., survival in breast and lung cancers [8, 9] and apoptosis in mCRC and glioblastoma multiforme [11], is likely to be associated to the heterogeneity of TRPA1-mediated Ca2+ signals.